|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 1.945 SEK | -1.02% |
|
+2.64% | +2.37% |
| 07-20 | Enzymatica CFO Holger Lembrér buys shares for 110,000 kronor | FW |
| 07-16 | Enzymatica AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 477M 409M 382M 351M 659M 45.59B 670M 4.51B 1.77B 22.86B 1.79B 1.75B 75.6B | P/E 2024 |
-5.73x | P/E 2025 | -8.89x |
|---|---|---|---|---|---|
| Enterprise Value | 445M 382M 356M 327M 615M 42.52B 625M 4.2B 1.65B 21.33B 1.67B 1.63B 70.51B | EV / Sales 2024 |
5.88x | EV / Sales 2025 | 7.96x |
| Free-Float |
56.66% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.02% | ||
| 1 week | +2.64% | ||
| Current month | +4.85% | ||
| 1 month | -11.59% | ||
| 3 months | -21.57% | ||
| 6 months | +5.14% | ||
| Current year | +2.37% |
| 1 week | 1.88 |  | 2.1 |
| 1 month | 1.61 | | 2.25 |
| Current year | 1.6 | | 3.4 |
| 1 year | 1.6 | | 3.4 |
| 3 years | 1.34 | | 5.45 |
| 5 years | 1.34 | | 12 |
| 10 years | 1.34 | | 24.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sana Alajmovic
CEO | Chief Executive Officer | - | 2026-01-31 |
Ulf Thomas Blom
COO | Chief Operating Officer | 61 | 2010-12-31 |
Holger Lembrér
DFI | Director of Finance/CFO | - | 2026-04-12 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 2016-02-14 | |
Bengt Baron
CHM | Chairman | 64 | 2016-12-18 |
| Director/Board Member | 71 | 2016-12-18 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/17/26 | Buy | Chief Financial Officer | 50,000 | 0.0206% | ||
| 12/30/25 | Buy | Chairman | 20,000 | 0.0082% | ||
| 12/27/25 | Buy | Chairman | 30,000 | 0.0124% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.02% | +2.64% | -22.20% | -22.51% | 50.04M | |
| +4.46% | +4.92% | +82.07% | +132.77% | 1,093B | |
| +0.85% | +4.81% | +53.77% | +63.38% | 653B | |
| +2.72% | +6.92% | +28.99% | +77.12% | 458B | |
| +1.80% | -0.41% | +43.52% | +44.05% | 355B | |
| +1.24% | +1.00% | +26.84% | +42.21% | 294B | |
| +2.07% | +1.74% | +2.66% | +13.06% | 248B | |
| +4.02% | +6.29% | +49.67% | +69.68% | 230B | |
| +1.05% | -2.52% | -13.83% | -52.13% | 203B | |
| +2.90% | +8.63% | +25.11% | +94.36% | 178B | |
| Average | +1.76% | +1.45% | +27.66% | +46.20% | 371.05B | |
| Weighted average by Cap. | +2.40% | +1.45% | +47.20% | +74.18% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 45.58M 39.09M 36.51M 33.49M 62.98M 4.36B 64.02M 431M 169M 2.18B 171M 167M 7.22B | 53.9M 46.24M 43.18M 39.61M 74.49M 5.15B 75.72M 509M 199M 2.58B 202M 198M 8.54B |
| Net income | -53.18M -45.62M -42.6M -39.08M -73.49M -5.08B -74.7M -503M -197M -2.55B -200M -195M -8.43B | -51.89M -44.51M -41.56M -38.13M -71.71M -4.96B -72.89M -490M -192M -2.49B -195M -191M -8.22B |
| Net Debt | -73.01M -62.63M -58.48M -53.66M -101M -6.98B -103M -690M -270M -3.5B -274M -268M -11.57B | -32.11M -27.54M -25.72M -23.6M -44.38M -3.07B -45.11M -303M -119M -1.54B -121M -118M -5.09B |
Employees
18
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-19 | SEK 1.945 | -1.02% | 89,096 |
| 26-08-18 | SEK 1.965 | -3.20% | 77,792 |
| 26-08-17 | SEK 2.030 | +4.10% | 48,825 |
| 26-08-14 | SEK 1.950 | -4.88% | 133,767 |
| 26-08-13 | SEK 2.050 | +4.86% | 80,161 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- ENZY Stock
Select your edition
All financial news and data tailored to specific country editions
